Affiliation:
1. Asklepios Paulinen Clinic
2. Federal State Budgetary Military Educational Institution of Higher Education «Military Medical Academy named after S.M. Kirov» of the Ministry of Defence of the Russian Federation
3. Southeast University
4. Ulm University
5. City Hospital
6. Flangzhou University
Abstract
The article presents the results of long-term clinical, molecular-biological and laboratory studies on combined poly-stage treatment of patients with colon cancer with liver metastases. The cytotoxicity of various chemotherapeutic agents for colorectal carcinoma in the lines of HT 29 and NMG 64/84 cells was studied by analysis of human colony-forming tumor (HTCA). In vitro studies on the suspension of tumor cells from remote liver metastases were carried out to determine the most effective chemotherapeutic agents for intra-arterial hepatic infusion (HAI). Individual choice of the scheme of systemic chemotherapy depends on the level of thymidylate synthetase (TS) in the tumor tissue. Long-term own clinical experience and analysis of world literature allow authors to state that stage resection of the liver (STR) in combination with regional (HAI) and systemic chemotherapy is the method of choice in the treatment of patients with colorectal cancer with unresectable liver metastases. In comparison with other treatment methods (ALPPS and TSH), STR has the least negative consequences and is beneficial from the tumor-biological point of view.
Publisher
FSBEI HE I.P. Pavlov SPbSMU MOH Russia
Reference23 articles.
1. Link K. H., Aigner K. R., Kuehn W. et al. Prospective ‘ correlative chemosensitivity testing in high-dose intraarterial chemotherapy for liver metastases // Cancer research. 1986. Vol. 46, № 9. P. 4837–4840.
2. Link K. H., Aigner K. R., Peschau K. et al. Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT 29 colorectal carcinoma cells // Cancer chemotherapy and pharmacology. 1988. Vol. 22, № 1. P. 58–62.
3. Link K. H., Leder G., Pillasch J. et al. In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols // Seminars in surgical oncology. 1998. Vol. 14, № 3. P. 189–201.
4. Link K. H., Kornmann M., Leder G. H. et al. Regional chemotherapy directed by individual chemosensitivity testing in vitro : a prospective decision-aiding trial // Clinical cancer research : an official J. the Am. Association for Cancer Research. 1996. Vol. 2, № 9. P. 1469–1474.
5. Link K. H., Sunelaitis E., Kornmann M. et al. Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival // Cancer. 2001. Vol. 92, № 11. P. 2746–2753.